Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.
about
Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.
P2860
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@en
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@nl
type
label
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@en
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@nl
prefLabel
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@en
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@nl
P2093
P2860
P1476
Serial analysis of 3D H-1 MRSI ...... apy that includes bevacizumab.
@en
P2093
Annette Molinaro
Janine M Lupo
Jason C Crane
Jennifer Clarke
Marram Olson
Michael Prados
Nicholas Butowski
Sarah J Nelson
Soonmee Cha
P2860
P2888
P304
P356
10.1007/S11060-016-2229-3
P50
P577
2016-08-17T00:00:00Z